Literature DB >> 2725561

Electrodiagnosis of human colchicine myoneuropathy.

R W Kuncl1, D R Cornblath, O Avila, G Duncan.   

Abstract

Colchicine may produce a neuromuscular disorder even when given in customary doses. We report the electrodiagnostic features in eight pathologically proven cases of colchicine-induced myoneuropathy. Myopathic motor unit potentials and early recruitment were found in proximal limb and truncal muscles, frequently with fibrillations, positive sharp waves, or complex repetitive discharges. These electromyographic findings correlated with the course of the weakness, which rapidly resolved within weeks of drug discontinuation, indicating that the major functional disturbance in the patients was myopathy. The accompanying signs of axonal neuropathy persisted longer, with little functional consequence. Although often misrecognized as polymyositis, colchicine myoneuropathy was identifiable by the rapid clinical and electrophysiologic improvement following drug withdrawal as well as by its distinctive morphology.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2725561     DOI: 10.1002/mus.880120504

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

1.  Acute neuromyopathy after colchicine treatment.

Authors:  J van der Naalt; H Haaxma-Reiche; A P van den Berg; B P Hazenberg; W M Molenaar
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

Review 2.  Toxic myopathies.

Authors:  Mamatha Pasnoor; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

3.  Amyloid myopathy presenting with respiratory failure.

Authors:  J Ashe; C O Borel; G Hart; R L Humphrey; D A Derrick; R W Kuncl
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

4.  Acute Colchicine-induced Neuromyopathy in a Patient Treated with Atorvastatin and Clarithromycin.

Authors:  José M Olmos-Martínez; Helena Molina; Cristina Salas; José M Olmos; José L Hernández
Journal:  Eur J Case Rep Intern Med       Date:  2019-03-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.